Inducare Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.05 Cr
as on 16-11-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.49 Cr
as on 16-11-2024
- Revenue 6.11%
(FY 2023)
- Profit -43.74%
(FY 2023)
- Ebitda 45.29%
(FY 2023)
- Net Worth 2.60%
(FY 2023)
- Total Assets 35.03%
(FY 2023)
About Inducare Pharma
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 1.05 Cr.
The company currently has active open charges totaling ₹13.49 Cr.
Monali Rajurkar, Vishal Salunke, and Ramadas Kute serve as directors at the Company.
- CIN/LLPIN
U24230PN2016PTC165320
- Company No.
165320
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jul 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Inducare Pharma Private Limited offer?
Inducare Pharma Private Limited offers a wide range of products and services, including Health Conditions, Fever, Ayurveda Products, Natural Hair & Skin Care, Mental Wellness, Pain Relief, Sexual Wellness, Sexual Health Supplements.
Who are the key members and board of directors at Inducare Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramadas Kute  | Director | 01-Jul-2016 | Current |
| Monali Rajurkar | Director | 01-Jul-2016 | Current |
| Vishal Salunke | Director | 23-Feb-2021 | Current |
Financial Performance of Inducare Pharma.
Inducare Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.11% increase. The company also saw a substantial fall in profitability, with a 43.74% decrease in profit. The company's net worth moved up by a moderate rise of 2.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Inducare Pharma?
In 2023, Inducare Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Inducare Pharmaceuticals And Research FoundationActive 5 years 11 monthsMonali Rajurkar and Ramadas Kute are mutual person
Charges (Loans)
₹13.49 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 13.49 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Nov 2023 | Others | ₹6.00 Cr | Open |
| 30 Aug 2021 | Others | ₹5.49 Cr | Open |
| 20 Mar 2019 | Others | ₹2.00 Cr | Open |
How Many Employees Work at Inducare Pharma?
Inducare Pharma has a workforce of 14 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inducare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inducare Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.